AGP Picks
View all

AGP Executive Report

Last update: 9 hours ago

Cancer Care: The European Medicines Agency’s medicines committee recommended Zybrivo with chemotherapy as a first-line option for adults with advanced non-squamous lung cancer; European Commission approval is still pending. The committee also backed belzutifan plus lenvatinib for some adults with advanced kidney cancer after prior treatment, with a final decision expected within two months. Rare Conditions: The European Commission approved Zeydovio for adults with short bowel syndrome, marking the first major treatment advance for the condition in Europe in more than a decade. Child Health: EU advisers recommended expanding Merck’s RSV prevention treatment to cover high-risk children through a second season. A final decision is expected within two months and would include Liechtenstein.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Nov. 3, 2026

Genki relaunches Native with month-to-month global health insurance

AGP

fallback image
Sep. 7, 2026

Swiss parabolic flight campaign pivots toward commercial space applications

AGP

fallback image
Jul. 3, 2026

European Commission authorizes CinnaGen’s osteoporosis biosimilar Zandoriah in EU

AGP

fallback image
Jul. 28, 2026

The European releases its Summer 2026 edition

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
From "Healthspans" To Blockchain – A Report From Apex Invest Europe Conference

From "Healthspans" To Blockchain – A Report From Apex Invest Europe Conference

Innovent Announces Positive CHMP Opinion, Recommending Zybrivo® (sintilimab) for First-Line Treatment of Non-squamous Non-Small Cell Lung Cancer

Innovent Announces Positive CHMP Opinion, Recommending Zybrivo® (sintilimab) for First-Line Treatment of Non-squamous Non-Small Cell Lung Cancer

Investigation launched as first human case of 'brain disease' found in EU country popular with UK tourists

Investigation launched as first human case of 'brain disease' found in EU country popular with UK tourists

Health Ministry Defends Child Organ Donation Bill But Stays Silent On Survey Asking Schoolchildren First Without Parents’ Informed Consent

Health Ministry Defends Child Organ Donation Bill But Stays Silent On Survey Asking Schoolchildren First Without Parents’ Informed Consent


fallback image
6 hours ago

European Commission Approves Revolution Medicines’ RASONQUE® (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

GlobeNewswire, Inc.

fallback image
Nov. 13, 2026

Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

GlobeNewswire, Inc.

fallback image
Nov. 3, 2026

Genki Relaunches Health Insurance for Nomads

EIN Presswire

fallback image
Oct. 23, 2026

SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026

GlobeNewswire, Inc.

fallback image
Oct. 15, 2026

Revolution Medicines’ RASONQUE(™) (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer

GlobeNewswire, Inc.

fallback image
Sep. 25, 2026

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Five EU Countries Set to Announce First Migrant Return Hub in Rwanda
Play
Five EU Countries Set to Announce First Migrant Return Hub in Rwanda
YouTube video thumbnail: Ukraine Needs a Starshield Alternative. Can Europe Deliver?
Play
Ukraine Needs a Starshield Alternative. Can Europe Deliver?
YouTube video thumbnail: Discover Affinity Group Publishing
Play
Discover Affinity Group Publishing
YouTube video thumbnail: Who Really Controls Europe’s €1.5 Trillion Food Supply?
Play
Who Really Controls Europe’s €1.5 Trillion Food Supply?
YouTube video thumbnail: How Trump's Threats and Tariffs Are Bringing Canada and the EU Closer
Play
How Trump's Threats and Tariffs Are Bringing Canada and the EU Closer

Video Title

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.